Frankfurt - Delayed Quote EUR

Perimeter Medical Imaging AI, Inc. (4PC.F)

Compare
0.2960
+0.0480
+(19.35%)
At close: January 3 at 8:10:23 AM GMT+1
Loading Chart for 4PC.F
DELL
  • Previous Close 0.2480
  • Open 0.2960
  • Bid 0.2320 x --
  • Ask 0.3560 x --
  • Day's Range 0.2960 - 0.2960
  • 52 Week Range 0.2000 - 0.8300
  • Volume 600
  • Avg. Volume 103
  • Market Cap (intraday) 28.236M
  • Beta (5Y Monthly) 1.60
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2300
  • Earnings Date Mar 26, 2025 - Mar 31, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Perimeter Medical Imaging AI, Inc., a medical technology company, provides advanced imaging tools that address unmet medical needs. The company offers Perimeter S-Series optical coherence tomography (OCT) imaging system that delivers resolution margin visualization of excised tissue specimens in the operating room. It also develops Perimeter B-series OCT with ImgAssist artificial intelligence technology for patients undergoing breast conservation surgery. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. is headquartered in Toronto, Canada.

perimetermed.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4PC.F

View More

Performance Overview: 4PC.F

Trailing total returns as of 1/3/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

4PC.F
18.40%
S&P/TSX Composite index
1.84%

1-Year Return

4PC.F
63.68%
S&P/TSX Composite index
20.13%

3-Year Return

4PC.F
89.08%
S&P/TSX Composite index
18.14%

5-Year Return

4PC.F
68.64%
S&P/TSX Composite index
46.63%

Compare To: 4PC.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4PC.F

View More

Valuation Measures

As of 1/2/2025
  • Market Cap

    28.24M

  • Enterprise Value

    19.18M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    26.64

  • Price/Book (mrq)

    1.87

  • Enterprise Value/Revenue

    31.73

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -59.35%

  • Return on Equity (ttm)

    -77.06%

  • Revenue (ttm)

    684.66k

  • Net Income Avi to Common (ttm)

    -11.17M

  • Diluted EPS (ttm)

    -0.2300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.49M

  • Total Debt/Equity (mrq)

    1.72%

  • Levered Free Cash Flow (ttm)

    -14.23M

Research Analysis: 4PC.F

View More